WeRide Inc. — Share Issue/Capital Change 2008

Jul 18, 2008

The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities.

==> picture [41 x 40] intentionally omitted <==

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED 遠東生物制藥科技有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 399)

CHANGE OF BOARD LOT SIZE

The board lot size of the Shares for trading on the Stock Exchange will be changed from 4,000 Shares to 20,000 Shares with effect from 9:30 a.m. on Monday, 21 July 2008.

References are made to the circular jointly issued by the Company and the Investor dated 28 May 2008 (the "Circular"), the announcements issued by the Company dated 13 June 2008, 20 June 2008, and 10 July 2008 respectively in relation to, amongst other things, the change of the board lot size of the shares of the Company (the “Announcements”). Unless otherwise stated, capitalised terms used herein shall have the same meanings as those defined in the Circular and the Announcements.

As stated in the announcement dated 20 June 2008, the proposed resolution to change of the board lot size of the shares of the Company with par value of HK$0.01 each (the “Shares”) for trading on the Stock Exchange from 4,000 Shares to 20,000 Shares was duly passed at the EGM held 20 June 2008 by the Shareholders. The board lot size of the Shares for trading on the Stock Exchange will be changed from 4,000 Shares to 20,000 Shares with effect from 9:30 a.m. on Monday, 21 July 2008.

The Company has procured Phillip Securities (HK) Limited to stand in the market to provide matching services for the odd lots of the Shares on a best effort basis, during the period from Monday, 21 July 2008 to Monday, 4 August 2008 (both dates inclusive). Holders of the Shares in odd lots (i.e. board lots which are not in integral multiples of 20,000 New Shares) who wish to take advantage of this matching facility either to dispose of their odd lots of Shares or to top up to board lots of 20,000 Shares, please contact Mr. Aric Au of Phillip Securities (HK) Limited at 11/F, United Centre, Queensway, Hong Kong at telephone number (852) 2277 6869 / 2277 6683 during office hours.

1

Holders of Shares in odd lots should note that successful matching of the sale and purchase of odd lots of Shares is not guaranteed. Shareholders are advised to consult their professional advisors if they are in doubt about the above arrangement.

By Order of the Board Far East Pharmaceutical Technology Company Limited Tai Kai Hing Director

Hong Kong, 18 July 2008

As at the date of this announcement, the Board comprises two executive Directors, namely Mr. Tai Kai Hing and Ms. Choi Suk Ching, and three independent non-executive Directors, namely Mr. Chiu Koon Shou, Victor, Mr. Chung Wai Man and Dr. Leung Wai Cheung.

Please also refer to the published version of this announcement on the Company’s website: http://www.feptcl-399.info/.

2